CT-95 in Advanced Cancers Associated With Mesothelin Expression

Clinical trial NCT06756035 · RECRUITING

Trial details

NCT number: NCT06756035
Sponsor: Context Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Mesothelin-Expressing Tumors Epithelial Ovarian Cancer Malignant Pleural Mesothelioma, Advanced Malignant Peritoneal Mesothelioma, Advanced Pancreatic Adenocarcinoma Advanced or Metastatic Lung Adenocarcinoma Metastatic Cholangiocarcinoma Advanced Cholangiocarcinoma Non-resectable Mesothelin-expressing Advanced Cancers Mesothelin-positive Advanced Malignant Solid Tumors Colorectal Cancer

Start date: 2025-03-31
Primary completion: 2026-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.